Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results.
about
Clinically important changes in individual and composite measures of rheumatoid arthritis activity: thresholds applicable in clinical trialsWorking status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.American College of Rheumatology/European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials.Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial.Interpreting measurements of physical function in clinical trials.Cost-effectiveness of modified-release prednisone in the treatment of moderate to severe rheumatoid arthritis with morning stiffness based on directly elicited public preference valuesWater-soluble fullerene (C60) inhibits the development of arthritis in the rat model of arthritis.The relationship between synovitis quantified by an ultrasound 7-joint inflammation score and physical disability in rheumatoid arthritis - a cohort study.Evidence for treating rheumatoid arthritis to target: results of a systematic literature search.Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study.Biologics-based therapy for the treatment of rheumatoid arthritis.Pharmacokinetic consideration of synthetic DMARDs in rheumatoid arthritis.Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.Patient-reported outcomes from a randomised phase III study of baricitinib in patients with rheumatoid arthritis and an inadequate response to biological agents (RA-BEACON).Periarticular osteoporosis of the forearm correlated with joint destruction and functional impairment in patients with rheumatoid arthritis.Achieving comprehensive disease control in patients with early and established rheumatoid arthritis treated with adalimumab plus methotrexate versus methotrexate alone.Relative responsiveness of physician/assessor-derived and patient-derived core set measures in rheumatoid arthritis trials.Goal-directed therapy for RA in routine practice is associated with improved function in patients with disease duration up to 15 years.Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis.Short-term efficacy of etanercept plus methotrexate vs combinations of disease-modifying anti-rheumatic drugs with methotrexate in established rheumatoid arthritis.Tofacitinib with methotrexate in third-line treatment of patients with active rheumatoid arthritis: patient-reported outcomes from a phase III trial.Sustained efficacy of certolizumab pegol added to methotrexate in the treatment of rheumatoid arthritis: 2-year results from the RAPID 1 trial.Effectiveness of a clinical practice intervention in early rheumatoid arthritis
P2860
Q28652859-EBCC0C37-D984-4FE8-8E08-C2F2917E4451Q33990812-8AC9C378-7E11-4AAE-8D07-EC71ECB09EFFQ35047250-856BB983-860C-4F71-A305-F6050B52C53CQ35174817-CCE1AEF3-E992-4EF2-8661-A1A78A827A90Q36171753-83D7C977-5038-4B9D-9BEC-E2CAC57A1DE8Q37278511-AB681084-B69D-46B5-9663-7B5ACB6C3AE8Q37417573-E0ED45EE-8AEF-4B3F-93B5-BCBEA8768D40Q37586470-C1961F86-5A80-46CC-A879-A9285EB56BD1Q37710906-D7E71593-F062-4029-B1BF-BC2893978614Q37715956-C97745A0-5FD2-42C9-A964-351565D16030Q37968143-4CA1B71D-D8B3-45CA-AD9E-1A89C6165D9FQ38097969-D1A78EC6-85EC-4DF4-AC7A-2B4D13605CDFQ38690324-B243B333-99BC-44EE-A43F-E9B73CCA6673Q39230189-8217161F-77FB-48FC-B87A-405D38C6B472Q40659876-04FDA7F5-73D3-4F85-A2BD-A8C2EA5BED0EQ42121483-2F6DBA17-E9D3-4300-86CF-983534E5BC05Q42562298-0641FA91-C9E0-4713-83A4-A75897E67893Q42578641-8A389389-8040-46A3-9CA8-4473FCC794A9Q43463510-E05E63C6-188D-44CF-A223-6FDA9BFA5FE6Q44083920-8D9EF0AE-3B77-4ADE-972C-4814D524D6C3Q44818742-9D0825EC-2C3E-49B1-B42E-7966239218CCQ49218023-1F878591-BE5D-4A17-BD04-852ED0A61819Q56966752-77C9A80C-4C4E-43AC-9AB8-B5EAD5D86937
P2860
Treatment-related improvement in physical function varies with duration of rheumatoid arthritis: a pooled analysis of clinical trial results.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Treatment-related improvement ...... sis of clinical trial results.
@ast
Treatment-related improvement ...... sis of clinical trial results.
@en
type
label
Treatment-related improvement ...... sis of clinical trial results.
@ast
Treatment-related improvement ...... sis of clinical trial results.
@en
prefLabel
Treatment-related improvement ...... sis of clinical trial results.
@ast
Treatment-related improvement ...... sis of clinical trial results.
@en
P2093
P356
P1476
Treatment-related improvement ...... sis of clinical trial results.
@en
P2093
P304
P356
10.1136/ARD.2007.071415
P407
P577
2007-07-20T00:00:00Z